We can't find the internet
Attempting to reconnect
18391.1 PFLS-LS
3-Dimensional Microtissues for Highly Predictive Drug Evaluation
Zusammenfassung
3-Dimensional Microtissues for Highly Predictive Drug Evaluation
Weitere Texte
Abstract
Failure rates in drug development are unsustainably high and are most often attributed to poor performance of|a lead compound regarding safety and/or efficacy. Improving the predictive power of preclinical stage in vitro|tests for new drug safety and efficacy is key to reducing attrition. CellSpring¿s 3D Bloom microtissue platform|has shown promise for achieving these goals. This CTI project will enable the development and validation of|3D microtissue models for preclinical drug safety, preclinical efficacy testing for novel chemotherapeutics, and|automated handling for high throughput applications.
Beteiligte
Chris Millan
Wirtschaftspartner
chris.millan@cellspring.co
CellSpring AG Chris Millan HPL D 16.1 / Otto-Stern-Weg 7 8093 Zürich ETH-Hönggerberg ZH CH
Marcy Zenobi-Wong
Kontaktperson
marcy.zenobi@hest.ethz.ch
ETH Zürich Marcy Zenobi-Wong Otto-Stern-weg 7 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-12-31
- Enddatum
- 2017-12-31
- Bewilligte Gesamtkosten
- CHF 344679.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T115 Medical technology 100.0%